Market revenue in 2024 | USD 89.5 million |
Market revenue in 2030 | USD 307.7 million |
Growth rate | 23.4% (CAGR from 2025 to 2030) |
Largest segment | Gmp grade |
Fastest growing segment | GMP Grade |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | R&D Grade, GMP Grade |
Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 104.02% in 2024. Horizon Databook has segmented the Canada plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
Canada plasmid DNA manufacturing market is anticipated to grow at a lucrative CAGR during the forecast period. This high growth can be attributed to the increasing healthcare expenditure and expanding pharmaceutical industry in the country, which is expected to fuel the demand for plasmid DNA manufacturing products for research & clinical purposes.
However, a majority of Canadian pharmaceutical and biotechnology industry players are small- and medium-sized companies, which limits the adoption of innovative and advanced plasmid DNA manufacturing products in the country.
Furthermore, extensive R&D initiatives being undertaken by local players for COVID-19 and cancer mitigation, as a result of continuous public-private funding, are anticipated to create lucrative opportunities for plasmid DNA manufacturing products in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Canada plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account